Migraine Headache: Clinical Trials

94 trials for Migraine Headache, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 15 unknown, 9 terminated, 7 recruiting. 40 Not applicable, 16 Phase 2, 14 Phase 3, 11 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable40Completed 17, Terminated 6, Unknown 6, Recruiting 5, Not yet recruiting 3, Active not recruiting 2, Withdrawn 1
Phase 216Completed 10, Unknown 4, Terminated 2
Phase 314Completed 11, Unknown 2, Withdrawn 1
Phase 411Completed 8, Recruiting 1, Terminated 1, Unknown 1
Phase 17Completed 4, Unknown 2, Not yet recruiting 1
Early Phase 11Completed 1

Follow Migraine Headache: new trials by email Literature Review of Migraine Headache trials Research Report on Migraine Headache

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
Active Remote Electrical Neuromodulation, Sham Remote Electrical Neuromodulation - Migraine, Migraine Headache
Not applicableNot yet recruitingUniversity of Calgary302026-10-012026-08-19
Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot
Cognitive behavioral therapy for migraine (CBTm), MEintervention - Migraine, Migraine Headache
Not applicableNot yet recruitingYale University242026-10-012026-08-31
Evaluation of the Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Foundational dietary supplement, Luteal phase dietary supplement add-on, Migraine phase dietary supplement add-on - Migraine, Migraine Disease
Not applicableNot yet recruitingMiracle Wellness LLC9202026-07-082026-06-08
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
Rimegepant, Zavegepant - Migraine, Migraine Disease
Phase 1Not yet recruitingUniversity of South Florida1002026-07-012026-06-25
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
Intervention yoga based exercises - Cluster Headache - Episodic and Chronic, Migraine Headache
Not applicableRecruitingKarolinska Institutet802026-05-012026-09-23
Light Exposure, Migraine Outcomes, and Sleep Quality
Ambient Lighting Condition - Migraine Headache, Sleep
Not applicableRecruitingArizona State University202026-03-242026-04-28
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study
Intervention yogabased movements - Cluster Headache - Episodic and Chronic, Migraine Headache
Not applicableActive not recruitingKarolinska Institutet202026-01-012026-09-23
Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd
Migraine Headache, Migraine
Enrolling by invitationLibbs Farmacêutica LTDA13422026-01-012025-12-19
The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine
Standard acupuncture, Electroacupuncture, Laser Acupuncture - Migraine, Migraine Headache
Not applicableActive not recruitingUniversity Medical Centre Ljubljana752025-11-032025-12-18
Evaluation of a Wearable Device for Acute Treatment of Migraines
Transcutaneous Electrical Nerve Stimulation (TENS) - Migraine, Migraine With or Without Aura
Not applicableCompletedHinge Health, Inc1602025-06-092025-10-30
Neuro-Complex & Multi Supplements for Migraine Prevention
Neuro-Complex and Multi - Migraine Headache, Migraine
Not applicableRecruitingBenfida, a department of Handi-Move1202025-05-152025-06-11
Cooling to Alleviate Migraine #3
Mi-Helper - Migraine With or Without Aura, Migraine
Not applicableCompletedMi-Helper, Inc.1562025-03-242026-02-10
Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment
Migraine Headache
Active not recruitingBeni-Suef University1162025-01-072025-01-29
Long-term Atogepant in Real-world Practice
Atogepant 60 mg, Headache diary, Patient-reported outcome measures - Migraine, Headache
CompletedFundación de Investigación Biomédica - Hospital Universitario de La Princesa5132024-06-012026-09-23
Vitamin K2 Supplementation in Adult Episodic Migraine
Vitamin K2 or menaquinone-7, Placebo - Migraine Headache, Arterial Stiffness
Not applicableRecruitingSola Aoun Bahous, M.D. Ph.D.1602024-03-062025-11-18
A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
Biodegradable occluder, Metal occluder - PFO - Patent Foramen Ovale, Migraine
Not applicableRecruitingChinese Academy of Medical Sciences, Fuwai Hospital4002024-03-012025-12-04
Migraine Attack Pain Phase Prediction Study
Migraine, Migraine Headache
Active not recruitingFundación de Investigación Biomédica - Hospital Universitario de La Princesa702023-10-092026-09-23
Oxygen in Migraine Treatment
oxygen - Migraine Headache, Oxygen
CompletedAnkara Ataturk Sanatorium Training and Research Hospital1602023-06-012025-04-11
Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)
blood samples collection - Migraine Headache, PFO - Patent Foramen Ovale
UnknownCentro Cardiologico Monzino1202023-05-182024-02-08
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Caffeine (200 mg), triptans, NSAID (Nonsteroidal anti-inflammatory drugs) - Migraine, Migraine Disease
Phase 4RecruitingAin Shams University1202023-04-262025-06-15

Showing 20 of 94. Sign in to see all of them.

Narrower conditions

Migraine Disorders (94)  ·  Headache (25)  ·  Migraine without Aura (6)  ·  Migraine with Aura (5)  ·  Bronchiolitis Obliterans Syndrome (3)  ·  Pain (3)  ·  Cluster Headache (2)  ·  Epilepsy (2)  ·  Foramen Ovale, Patent (2)  ·  Headache Disorders (2)  ·  Tension-Type Headache (2)  ·  Chronic Pain (1)  ·  Cognitive Dysfunction (1)  ·  Fasting (1)  ·  Headache Disorders, Primary (1)

Broader conditions

Brain Diseases (94)  ·  Central Nervous System Diseases (94)  ·  Nervous System Diseases (94)  ·  Headache Disorders, Primary (93)  ·  Headache Disorders (92)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Neurologic Manifestations (26)  ·  Signs and Symptoms (26)  ·  Pain (22)  ·  Behavior (3)  ·  Bronchial Diseases (3)  ·  Bronchiolitis (3)  ·  Bronchiolitis Obliterans (3)  ·  Bronchitis (3)  ·  Graft vs Host Disease (3)

Interventions

Sumatriptan (5)  ·  rizatriptan (5)  ·  Propofol (3)  ·  Saline Solution (3)  ·  Anti-Inflammatory Agents, Non-Steroidal (2)  ·  Caffeine (2)  ·  Celecoxib (2)  ·  Dihydroergotamine (2)  ·  Ketorolac Tromethamine (2)  ·  Lidocaine (2)  ·  Metoclopramide (2)  ·  Propranolol (2)  ·  Psilocybin (2)  ·  Tryptamines (2)  ·  erenumab (2)

Sponsors

Eli Lilly and Company (4)  ·  Organon and Co (4)  ·  Yale University (3)  ·  Ain Shams University (2)  ·  Alexza Pharmaceuticals, Inc. (2)  ·  BioDelivery Sciences International (2)  ·  Fundación de Investigación Biomédica - Hospital Universitario de La Princesa (2)  ·  Impel Pharmaceuticals (2)  ·  Karolinska Institutet (2)  ·  Shiraz University of Medical Sciences (2)  ·  The Cleveland Clinic (2)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Albert Einstein Healthcare Network (1)  ·  Amgen (1)  ·  Ankara Ataturk Sanatorium Training and Research Hospital (1)

Countries

United States (54)  ·  Canada (6)  ·  Spain (4)  ·  Australia (3)  ·  Egypt (3)  ·  Finland (3)  ·  Iran (3)  ·  Italy (3)  ·  United Kingdom (3)  ·  Brazil (2)  ·  Hungary (2)  ·  Poland (2)  ·  Sweden (2)  ·  Turkey (Türkiye) (2)  ·  Austria (1)

Top investigators

Ana Beatriz Gago Veiga (2)  ·  Abdolhamid Shariat, MD, Assistant Professor (1)  ·  Alex Rosin, MD (1)  ·  Alexandra Hovaguimian, MD (1)  ·  Anna Huguet, PhD (1)  ·  Arthur Elkind, MD (1)  ·  Ayat F Mohamed (1)  ·  Caren Behar, MD (1)  ·  Christopher Jones, MD (1)  ·  Daniel A Spyker, PhD, MD (1)  ·  Daniel Laskowitz, MD (1)

Results publications

PMID 11284464, PMID 32576229, PMID 10412281, PMID 11284463, PMID 11422095, PMID 12841373, PMID 16052775, PMID 16553016, PMID 17165292, PMID 17323720, PMID 17659990, PMID 19250995, PMID 19548407, PMID 20194385, PMID 20880898, PMID 21837291, PMID 22001666, PMID 22467991, PMID 22480810, PMID 23115152, PMID 23385700, PMID 23406052, PMID 23427844, PMID 23643652, PMID 23756884, PMID 23876282, PMID 23953215, PMID 24110501, PMID 24168714, PMID 24235894, PMID 24247058, PMID 24269982, PMID 24392483, PMID 24596907, PMID 24635459, PMID 24843394, PMID 24864394, PMID 24923944, PMID 24942041, PMID 25004051, PMID 25127173, PMID 25191887, PMID 25283030, PMID 25355310, PMID 25363423, PMID 25416461, PMID 25505035, PMID 25512839, PMID 25633110, PMID 25859272

NIH funding

1UG3AT013498-01 (1), 2018 (1), 2019 (1), UL1TR000135 (1)